Integrin a2pl is a cell surface adhesion receptor for collagen and echovirus 1. Here we localized the epitopes for anti-az monoclonal antibodies using interspecies (humadbovine) a2 chimeras with different lengths of human a2 sequence on the amino-terminal side and sitedirected mutagenesis. The antibodies that block the collagen and/or echovirus 1 binding to human a2pl ( 
Integrins are a supergene family of cell adhesion receptors. This family is composed of at least 13 a subunits and 8 /3 subunits. Integrins recognize multiple ligands and mediate cell-cell and cell-extracellular matrix interactions. Integrin a2pl is a major collagen receptor in fibroblasts, platelets, and leukocytes (1) (2) (3) (4) (5) (6) . a 2 p l contributes to the three-dimensional type I collagen gel contraction and the reorganization of collagen by fibroblast (7, 8) . a2pl is also involved in the migration of tumor cells within collagenous matrices (9, 10) and in platelet aggregation induced by collagen (11) . The ligand specificity of a 2 p l may be different from cell type to cell type; platelet a 2 p l binds only to collagen, but endothelial cell a 2 p l binds to collagen, laminin, and fibronectin (12, 13) . Some anti-a2 monoclonal antibodies (mAbs)' (5E8,6F1, RMAC11, and PlH5) have been reported to inhibit the interaction between a2pl and extracellular matrix proteins ( 5 , 14-16) ( Table I ). The a2pl is also AAlO + + (17, 18) a receptor for echovirus 1, and anti-a2 mAbs 5E8, 12F1, and A A l O block echovirus 1 binding to cells (17, 18) (Table I ). a2pl has also been shown to be involved in cell-cell interaction (19, 20) , probably by interacting with a3pl (21). The a2 chain consists of a large extracellular domain, a transmembrane domain, and a small cytoplasmic segment (22). In addition to common characteristics of integrin a chain, (the well conserved Cys residues, three metal binding domains of the general structure DXDXDGXXD, and transmembrane domain), a2 chain has an I (inserted, interactive (25,261, complement C2 (27) , factor B (281, the aL subunit of lymphocyte function-associated antigen-1 (aLp21, the aM subunit of Mac-1 (aMp2) (29) (30) (31) , aX subunit of p150,95 (32) , and the a1 subunit of alp1 (33, 34) . Since cartilage matrix protein, a l p l , and vWF interact with collagens, the I domain of the a2 subunit has been speculated to be a putative collagen binding domain. There has been, however, no evidence for the role of a2 I domain in the ligandla2pl interactions.
In the present study, we located the putative ligand binding sites in the a2 subunit by mapping epitopes for function-inhibiting mAbs using interspecies a 2 chimeras expressed on Chinese hamster ovary (CHO) cells. The epitopes of the function blocking mAbs are mapped within or close to a small region (residues 173-259) of the I domain. Notably, mutations of Asp-151 and Asp-254 of a 2 block the binding of a 2 p l to collagen. The data suggest that the I domain (residues 140-349) is involved in liganda2pl interaction and that echovirus 1 binding sites may be adjacent to or overlapping with the collagen binding sites.
EXPERIMENTAL. PROCEDURES
Monoclonal Antibodies"BE8 (14) Cloning a n d Sequencing of Bovine a2 cDNA from Bovine Endothelial Cells-A fragment of bovine a 2 cDNA was cloned by amplification using between integrin a subunit (5'-TGGTAACTGG?TGGTTCACCC-3' and polymerase chain reaction (PCR) with conserved nucleotide sequence 5'-CACAGAGTAACCTAAATATGA-3') and bovine endothelial cell cDNA a s template. Total RNA was purified from cultured bovine endothelial cells using acid guanidium thiocyanate-phenol-chloroform extraction (36) . Single-stranded cDNA was synthesized by reverse transcriptase with random primer using cDNA cycle kit, and PCR products .egrin cy2 Subunit were subcloned into PCRII vector (Invitrogen, San Diego, CAI. Bovine endothelial cell AZAP cDNA library (Stratagene) was screened by hybridization for larger cDNA fragments that cover the entire bovine a2 with the PCR fragment (nucleotide residues 231-1371, 1.1 kb). Several different cDNA clones were obtained. The two cDNA fragments (hZ38 (2.1 kb, nucleotide residues 132-2273) and hZ33 (2.4 kb, nucleotide residues 1262-3650) in Bluescript SK(-)) were fused using a common XhoI site. The reconstructed 3.6-kb cDNA (hZ38-33) contained the whole mature bovine a2 peptide sequence and one residue from the signal sequence (97% of the coding sequence). The reconstructed cDNA was used to make chimeras with human a 2 cDNA.
Construction of HumanlBouine Chimeric a2 cDNA"h454h a2 ( 
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amino-terminal 454 amino acid residues out of 1152 residues of the mature a2 derive from human a2, and the rest derive from bovine a2) was constructed by fusing the bovine and human a2 cDNA 2.72 (22) using a common BstEII site. For h172h a 2 chimera, human a 2 fragment was prepared by PCR amplification using synthetic oligonucleotide primer with an artificial StuI site (5'-GCCTATATCAAGGCCV-GTAC-3'). The fragment was then fused with bovine a2 fragments using the StuI site. The h320h a2 chimera was prepared as described above except that synthetic oligonucleotide 5'-C'ITTTCTAGTAGATCTGCT-TCATC-3' with an artificial BglII site was used. For h259h a2, PCR fragments of human and bovine a 2 cDNA (encoding 1-259 and 260-1152 residues, respectively) with artificial BamHI site at the boundary were prepared using synthetic oligonucleotides 5"GATGGATCCAAGT- bly expressing wt human a 2 or chimeric a2 subunit were surface '2sI-labeled, and the detergent extracts were immunome-TGAAAGCTGTGAVG-3' and 5'-CATGGATCCATCATGTGAVCAC-CGTC-3', respectively, and then fused using the BamHI site. The nucleotide sequence of the PCR products was confirmed by sequencing and the chimeric cDNAs were subcloned into pBJ-1 vector (37) for expression.
Adhesion of CHO Cells to Collagen-Wells of 96-well microtiter plate (Immulon-2, Dynatech Laboratories, Inc., Chantilly, VA) were coated with type I collagen (IO pglml) a t 4 "C overnight. The other protein binding sites were blocked by incubating with 1% (wlv) bovine serum albumin (Calbiochem) for 30 min a t room temperature, and then were washed twice with PBS (10 mM phosphate, 0.15 M NaCI, pH 7.4). Cells were harvested with 3.5 mM EDTA in PBS and washed twice with Dulbecco's modified Eagle's medium. lo5 cells (in 100 pl of Dulbecco's modified Eagle's medium) were added to each well and incubated for 1 h a t 37 "C. The wells were rinsed with PBS three times to remove unbound cells, and bound cells were quantified by assaying endogenous phosphatase activity (38).
Other Methods-Site-directed mutagenesis was carried out by unique site elimination with double-stranded vector (39). Transfection of cDNA into CHO cells, flow cytometric analysis, and immunoprecipitation were carried out as previously described (40, 41) .
RESULTS
Cloning and Sequencing of Bovine 02 cDNA from Bovine Endothelial Cells-To facilitate mapping epitopes for anti-human a2 mAbs, bovine a2 cDNA was cloned and sequenced. A small cDNA fragment for bovine a2 was obtained by PCR amplification with conserved nucleotide sequences between integrin a subunit as primers and bovine endothelial cell cDNA as template. Larger cDNA fragments were cloned from bovine endothelial cell cDNA library by hybridization with a PCR fragment of bovine cDNA. The cDNA (3.6 kb) sequence recon-
antimAb 6F1
a2 peptide -n mouse IgG I I cipitated-with mAb 6 F l or anti-a2 choplasmic peptide polyclonal antibody. The immunoprecipitated materials were analyzed by SDS-polyacrylamide gel (7%) electrophoresis under non-reducing con-
a2-
ditions. Dried gels were exposed overnight. The data indicate that a2 chimeras with expected size are expressed on CHO cells.
- The reactivity of 5E8 was reduced as compared to wt a2 but not completely lost using either CHO cells transiently or stably expressing h179h a 2 chimera. structed from two overlapping cDNA fragments contained a whole mature peptide sequence of bovine a2. Homology between human and bovine a2 subunit mature peptide sequences is 86% (Fig. 1) .
P1-
Expression of HumanlBouine a2 Chimeras on CHO CellsAll the anti-a2 mAbs tested recognized human a2 (using CHO cells expressing human a2) but not bovine a2 (using bovine endothelial cells) except for mAb PlH5, which recognized both (data not shown). To locate the binding sequences for human a2-specific mAbs, humadbovine a2 chimeras that have different lengths of human a2 sequences on the amino-terminal side were developed (Fig. 2) . This strategy is based on the fact that bovine a2 is 86% homologous to human a2 but is not recognized by most of the anti-human a2 mAbs. The chimeric cDNAs were used to transfect CHO cells, and wild-type (wt) or chimeric a2 subunits were transiently or stably expressed on CHO cells.
The extracts of the surface labeled CHO cells stably expressing the wt a2 or chimeric a2 were immunoprecipitated with mAb 6F1 or anti-a2-cytoplasmic peptide polyclonal antibody. The immunoprecipitation detected a band with a molecular mass of 150 kDa (non-reduced), suggesting that the wt and chimeric a2 subunits are expressed on the surface of CHO cells (Fig. 3 ). An associated band (110 kDa) is most probably endogenous hamster p l subunit co-precipitated with the a2 chimeras. 6F1 did not recognize the h172h a2, since 6F1 epitope was lost in this chimera (shown below). The reactivity of anti-human cytoplasmic a2 peptide antibody to h172h1 a2 chimera was weak, probably because the cytoplasmic domain of the chimera derives from bovine a2. There are three amino acid residue differences in the cytoplasmic domain between human and bovine a2 (Fig. 1) . CHO cells expressing wt and chimeric a2 subunits adhered to collagen-coated plastic, but parent CHO cells did not (data not shown), suggesting the a2 chimeras are functional and properly folded.
Localization of Epitopes for Function-blocking 0 . 2 mAbs within the I Domain-The reactivity of the anti-a2 mAbs toward these a2 chimeras was tested by flow cytometry ( Table 11) . The mAbs 6F1, RMAC11, PlE6, P4B4,12F1, and AAlO reacted with wt human a2, h454h a2 (amino-terminal 454 residues derive from human a2 and the rest from bovine a2), h320ha2, and h259h a2, but not with h/172b a2. This suggests that these antibodies recognize epitopes within residues 173-259. The I domain spans residues 140-349. These data suggest that the I domain is involved in the interaction of a 2 p l with collagen and echovirus 1, since 6F1, RMAC11, 12F1, and AAlO have been reported to block the interaction of a 2 p l with collagen and/or echovirus 1 (Table 11) . While P4B4 has been reported not to be inhibitory and P1E6 slightly inhibitory to a2pllcollagen interaction, the present findings suggest P4B4 and P1E6 may affect a2pllechovirus 1 interaction.
The regions that are recognized by P1H5 and 5E8 were not identified using interspecies a2 chimeras, since P1H5 crossreact bovine a 2 and the reactivity of 5E8 was not completely lost in h172h a2 probably due t o weak cross-reactivity of 5E8 to bovine a2. We found, however, mutations of Asp-160 and Arg-242 to Ala block the binding of P1H5 and 5E8, respectively, as assessed by flow cytometry of stably transfected CHO cells (Table 111 ). These findings suggest that the epitopes for P1H5 and 5E8 are located close to or within the region 173-259.
Asp-151 and Asp254 Are Essential for Binding of cr2pl to Collagen-Mutations in the I domain at positions 140 and 242 have been reported to block the divalent cation binding to the I domain and the iC3b binding to Mac-1 (42) . Since these mutations are located within the I domain close to or within the putative ligand binding sites (residues 173-2591, we made the homologous mutations in 1x2. The effects of the mutations of these residues to alanine on binding to collagen were examined. The mutant a2 cDNAs were used to transfect CHO cells and CHO cell clones expressing the mutants were selected. CHO cells expressing wt or mutant a2 were plated on plastic coated with collagen or fibronectin, and the ability to bind to these substrates was examined (Table IV) . Wild-type a2-CHO cells adhere to collagen, but parent CHO, D151A a2-CHO, and D254A a2-CHO cells did not significantly adhere to collagen. Adhesion of these cells to fibronectin mediated by endogenous a5/31 was not affected by the mutations in 012. The data suggest that Asp-151 and Asp-254 of a2 may be critical for binding of a 2 p l to collagen. D151A and D254A mutations did not affect the reactivity of the mAbs tested. DISCUSSION We established in this study that epitopes for anti-a2 mAbs that block the interaction with collagen and/or echovirus 1 were located within a region (residues 173-259) of the I domain (Fig.  4) . In addition, Asp-160 is critical for the binding of PlH5, and Arg-242 for 5E8. These findings suggest that putative collagen and echovirus 1 binding sites are located within a region of the I domain. If we assume function blocking mAbs bind close to the ligand binding sites, the echovirus 1 binding sites are adjacent to or overlapping with the collagen binding sites within the I domain. Although the effects of the mAbs 6F1, RMAC11, PlE6, PlH5, and P4B4 on the echovirus 1 infection are unknown, they may affect echovirus 1 infection, since their epitopes were mapped within a region similar to the epitope region for the mAbs that block echovirus 1 infection (12F1, AA10, and 5E8; Ref. 18) in this study. In accord with results of the present mapping study, we found that the I domain portion of bacterial a2 I domain fusion protein is recognized by all the anti-a2 mAbs listed in Table I . ' Interestingly, the putative ligand binding sites of a2 (residues 173-259) overlap with the CNBr fragments from A1 and A3 domains of vWF (termed M11 and M20, residues 542-622 and 948-998 of vWF, respectively) that have been reported to inhibit the lZ5I-vWF binding to type I11 collagen (43), suggesting that there are collagen binding motifs common to a2 (173-2591, M11 and M20 peptides of vWF within the overlapping region. These findings suggest that the putative ligand binding sites of a2, which were identified by mAb epitope mapping in this study, may be involved in ligand recognition.
We also established mutation of the 2 oxygenated amino acid residues (Asp-151 and Asp-254) of the I domain to Ala blocked the binding of collagen. D140GS/AGA and D242A mutation of the I domain of aM have been reported to block the divalent cation binding to the I domain and the iC3b binding to Mac-1 (42) . Asp-140 and Asp-242 of aM of Mac-1 correspond to Asp-151 and Asp-254 of a2, respectively. These findings suggest that the effects of the mutations of Asp-151 and Asp-254 of a2 might also be due to the defect in divalent metal binding to the I domain. Since Asp-151 and Asp-254 of a2 are well conserved among different I domains, it is possible that these residues are critical to the ligand/I domain interaction regardless of the ligand species (collagen, iC3b, etc.) through divalent cation binding. In addition, P1H5 and 5E8 might inhibit ligand binding through blocking of divalent cation binding to the I domain because these mAbs bind close to the potential cation binding sites (Fig. 4) . However, a cation requirement for ligand/a2 I domain interaction or interaction of divalent cations to the a2 I domain has not been reported. There is another possibility that Asp-151 and/or Asp-254 of a2 are directly involved in ligand binding.
Recently, an activating anti-cuL mAb MEM-83 was mapped to the I domain of the aL subunit (44). In addition, inhibiting anti-aM mAbs were mapped to the I domain of the aM subunit (45) . These findings suggested that I domains of p2 integrins are involved in the regulation of integrin avidity and ligand T. Kamata and Y. Takada, unpublished data.
recognition. It will be interesting to examine if the region of p2 integrin a subunit corresponding to the putative ligand binding region in the a2 I domain is similarly involved in the p2 integridigand interactions.
